Clinical trial
Safety Study of Avian Flu Vaccine
NCT00408109 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00408109 |
|---|---|
| Title | Safety Study of Avian Flu Vaccine |
| Official title | VRC 304: A Phase I Study of the Safety and Immunogenicity of a Recombinant DNA Plasmid Vaccine (VRC-AVIDNA036-00-VP), Encoding for the Influenza Virus H5 Hemagglutinin Protein in Healthy Adults |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Influenza A Virus, H5N1 Subtype, Influenzavirus A, Orthomyxoviridae, H5N1 Virus |
| Intervention type | Drug |
| Interventions | VRC-AVIDNA036-00-VP |
| Enrollment | 45 |
| Start date | Dec 4, 2006 |
| Completion | Aug 28, 2008 |
| First posted | Dec 6, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: